- Home
- PAC vs SNN Comparison
PAC vs SNN Comparison
Compare PAC & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAC | SNN |
|---|---|---|
| Founded | 1998 | 1856 |
| Country | Mexico | United Kingdom |
| Employees | N/A | N/A |
| Industry | Aerospace | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.3B |
| IPO Year | 2006 | 2002 |
Fundamental Metrics
Financial Performance| Metric | PAC | SNN |
|---|---|---|
| Price | $220.88 | $30.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $246.20 | $32.32 |
| AVG Volume (30 Days) | 140.9K | ★ 1.1M |
| Earning Date | 10-19-2026 | 08-04-2026 |
| Dividend Yield | N/A | ★ 2.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.09 | $4.85 |
| Revenue Next Year | $11.37 | $5.25 |
| P/E Ratio | ★ $27.29 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $192.65 | $26.30 |
| 52 Week High | $300.41 | $37.09 |
Technical Indicators
Market Signals| Indicator | PAC | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 60.71 | 64.19 |
| Support Level | $197.48 | $29.18 |
| Resistance Level | $225.86 | $30.52 |
| Average True Range (ATR) | 7.46 | 0.46 |
| MACD | 2.29 | 0.26 |
| Stochastic Oscillator | 80.54 | 71.80 |
Price Performance
Historical ComparisonAbout PAC Grupo Aeroportuario Del Pacifico
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the operation, maintenance, and development of 12 international airports in Mexico and two international airports in Jamaica. The company's segment includes Guadalajara, Tijuana, Puerto Vallarta, San Jose del Cabo, Montego Bay, Hermosillo, and Guanajuato airports. It generates the maximum revenue from the Guadalajara segment.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.